Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00267436 · ClinicalTrials.gov registry record · Phase 1
Adopting and Demonstrating the Adaptation of Prevention Techniques: Community PROMISE PLUS
A Phase 1 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 1
- Development phase
- 574
- Enrollment target
NCT00267436: Completed Phase 1 study, sponsored by Centers for Disease Control and Prevention.
NCT00267436 is a Phase 1 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 574 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (857% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00267436, a Phase 1 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 574 participants
- Enrollment target
Study Summary
This project will pilot test a step-by-step guide developed by CDC for organizations to engage in evidence-based adaptation of interventions previously shown to be effective in research settings for use in real world applications. The second purpose of the program is to evaluate the adapted intervention to determine if it is effective in changing behavior of HIV+ African American men who have sex with other men.
Interventions
- BEHAVIORAL Community PROMISE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 574 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-02 |
| Phase | Phase 1 |
What the finished NCT00267436 record still lists
NCT00267436 is an interventional study that assigns participants to a tested intervention. The registered 574 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (857% higher).
The record links to 0 conditions, and to 1 intervention - of which Community PROMISE is the first listed.
NCT00267436 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00267436 about?
NCT00267436 is a clinical study titled "Adopting and Demonstrating the Adaptation of Prevention Techniques: Community PROMISE PLUS". This project will pilot test a step-by-step guide developed by CDC for organizations to engage in evidence-based adaptation of interventions previously shown to be effective in research settings for use in real world applications. The second purpose of the program is to evaluate the adapted interven...
What is the current status of trial NCT00267436?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 574 participants. The study started on 2006-07. Estimated completion is 2007-02.
What interventions are being tested in trial NCT00267436?
The interventions under investigation include: Community PROMISE (BEHAVIORAL).
Who is sponsoring clinical trial NCT00267436?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00267436's enrollment target sits among peer trials
574 33rd of 2000 higher than 1,967 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07349537 · 574 participants · Phase 1
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- NCT02610439 · 575 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
- NCT05919264 · 575 participants · Phase 1
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- NCT06583148 · 575 participants · NA
A Smoke-Free Home Intervention in Tribal Communities
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia